Secondary analysis 10 years after the KEEPS trial (266 recently menopausal women): 4 years of oral conjugated equine estrogens or transdermal 17β-estradiol vs placebo showed no difference in amyloid PET or structural MRI biomarkers.
Secondary analysisn = 266 women
Kantarci et al. Long-term amyloid PET and MRI outcomes in a menopausal hormone therapy trial